SPH Notice – FMR LLC

100080615/3821103.1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the end of the
form.
To New Zealand Stock Exchange
and
To Ryman Healthcare Ltd.
Relevant event being disclosed: Movement of 1% or more in the substantial holding
Date of relevant event:11 May 2018
Date this disclosure made: 14 May 2018
Date last disclosure made: 11 May 2018
Substantial product holder(s) giving disclosure
Full name(s): FMR LLC and the entities listed in Annexure A (“FMR”)
Summary of substantial holding
Class of quoted voting products: Ordinary share
Summary for FMR
For this disclosure,—
(a) total number held in class: 33,662,403
(b) total in class: 500,000,000
(c) total percentage held in class: 6.73%
For last disclosure,—
(a) total number held in class: 25,464,919
(b) total in class: 500,000,000
(c) total percentage held in class: 5.09%

100080615/3821103.1
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure:
Date of
Change
Person
whose
relevant
interest
changed
Nature of
change
Consideration
given in relation
to change
Class and
Number of
Securities
Person’s votes
affected
NZD Common stock Common stock
11-May-18 FMR BUY 11.40 2,603,200 2,603,200
11-May-18 FMR BUY 11.40 4,050,804 4,050,804
11-May-18 FMR BUY 11.40 210,341 210,341
11-May-18 FMR BUY 11.40 962,802 962,802
11-May-18 FMR BUY 11.40 129,609 129,609
11-May-18 FMR BUY 11.40 240,728 240,728

Total Buys 8,197,484 8,197,484

Details after relevant event
Details for: Refer to Annexure A
Nature of relevant interest(s): Investment discretion and/or voting power
For that relevant interest,—
(a) number held in class: Refer to Annexure A
(b) percentage held in class: Refer to Annexure A
(c) current registered holder(s): Refer to Annexure A
(d) registered holder(s) once transfers are registered: N/A
For a derivative relevant interest, also—
(a) type of derivative: N/A
(b) details of derivative: N/A
(c) parties to the derivative: N/A
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: N/A
Additional information
Address(es) of substantial product holder(s): Refer to annexure A
Contact details: Ryo Sato, Regulatory Reporting Manager, FIL Asia Holdings Pte Limited,
+852 2629 2657

100080615/3821103.1
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: N/A
Certification
I, Ryo Sato, certify that, to the best of my knowledge and belief, the information contained
in this disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.

________________________________

Dated: 14 May 2018

Ryo Sato
Regulatory Reporting Manager
Duly authorised under Powers of Attorney by and on behalf of FMR LLC.